IHT planning favourite is looking more encouraging
This world-leading specialist in tissue-healing technologies has announced encouraging full year results. With plenty of investment in R&D and a more positive outlook than we have seen for a while, the future looks bright for this high-quality AIM company, which is a favourite for many Inheritance Tax planning portfolios.
Background Advanced Medical Solutions Group (AIM:AMS) was founded in 1991 in Winsford, Cheshire. It was originally set up to offer research & development, manufacturing and sales & marketing capabilities, providing advanced wound care products for major healthcare companies. Following a series of acquisitions, and plenty of organic growth, it has developed a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants. These are marketed under its brands LiquiBand®, RESORBA®, LiquiBandFix8® and Seal-G®. It also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under…